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ABSTRACT: Sticholysins are pore-forming toxins produced by sea anemones
that are members of the actinoporin family. They exert their activity by forming
pores on membranes, provided they have sphingomyelin. To assemble into pores,
specific recognition, binding, and oligomerization are required. While recognition
and binding have been extensively studied, delving into the oligomerization
process and the stoichiometry of the pores has been more difficult. Here, we
present evidence that these toxins are capable of oligomerizing in solution and
suggesting that the interaction of sticholysin II (StnII) with its isoform sticholysin
I (StnI) is stronger than that of StnI with itself. We also show that the
stoichiometry of the final, thermodynamically stable StnI pores is, at least,
heptameric. Furthermore, our results indicate that this association maintains its
oligomerization number when StnII is included, indicating that the stoichiometry
of StnII is also of that order, and not tetrameric, as previously thought. These results are compatible with the stoichiometry observed
for the crystallized pore of FraC, another very similar actinoporin produced by a different sea anemone species. Our results also
indicate that the stoichiometry of actinoporin pores in equilibrium is conserved regardless of the particular composition of a given
pore ensemble, which we have shown for mixed sticholysin pores.
The production of venom containing very similar toxins isa common feature of sea anemones around the globe.1−8
Sticholysins are similar toxic proteins produced by the
Caribbean Sea anemone Stichodactyla helianthus.9,10 They
belong to a family of cytolytic proteins known as actinoporins.
They are pore-forming toxins and, as such, exert their activity
by creating pores in selected target membranes.11−13 These
membranes feature sphingomyelin (SM), a lipid that is
specifically recognized by these proteins and whose absence
in the membranes of sea anemones provides the basis for
avoiding self-toxicity.9,10,14−19
Thanks to years of research, many details of the functionality
of these proteins have been elucidated. The knowledge
acquired includes the role of specific residues and the influence
of the lipid composition of the membrane. SM selectivity, the
role of tryptophan residues, the enhancing effect of cholesterol
(Chol) on activity, and the crucial intervention of the N-
terminal α-helix in the process of pore formation are some of
the aspects that have been elucidated.9,10,14−16,20−26 Studies
have traditionally been performed using one (or several) of the
following proteins: sticholysins I and II (StnI, UniProtKB
P81662; and StnII, UniProtKB P07845), equinatoxin II
(EqtII), and/or fragaceatoxin C (FraC). The soluble,
monomeric structures of these four proteins have been
revealed in atomic detail.7,27−30 All of them display a common
fold, which consists of a β-sandwich flanked by two α-helices
(Figure 1). The α-helix located at the N-terminus is
responsible for membrane penetration.22−26
The aforementioned soluble structures were obtained using
X-ray crystallography and/or nuclear magnetic resonance.
However, the structure of the pore complex into which these
toxins assemble in SM-containing membranes, revealing all of
the structural changes and the stoichiometry of these
complexes, has not been easy to resolve. To penetrate the
membrane and form a pore, the structure of an actinoporin has
to undergo conformational changes. These changes include
oligomerization, the concomitant monomer−monomer con-
tacts, and the deployment and extension of the N-terminal α-
helix, the most significant one at the monomer level. All of
these are structural modifications that take place exclusively in
the presence of suitable membranes.
Therefore, the presence of lipids appears to be necessary if
the complexes formed by actinoporins are to be understood.
Accordingly, early attempts to understand these complexes
used StnII crystallized on egg phosphatidylcholine (egg-PC)
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and dioleoylphosphatidylcholine (DOPC) monolayers, with
the crystallization process appearing to force membrane
binding despite the absence of SM.28 These experiments
yielded three-dimensional maps at 18 Å resolution that were
used to fit the previously available structure of the soluble
monomers. In this case, it appeared that the stoichiometry of
StnII pores was tetrameric. Years later, a new approach was
devised. It overcame the limitation imposed by lipids for X-ray
crystallography by removing or replacing them with detergents
in a way that, in principle, conserved the lipid−protein and
protein−protein interactions that stabilize the membrane-
bound conformation of actinoporins.32,33 These experiments
were performed using FraC. Several structures were obtained,
including that of a nonameric prepore ensemble and, most
importantly, an octameric pore, at a resolution of 3.2 Å.33
Tetrameric, heptameric, and octameric ensembles, repre-
sented by the toroidal pore, the conical pore, and the hybrid
pore models, are currently the most accepted candidates for
the pore structures in the field of actinoporins. There are,
however, many clear indications about the simultaneity of
several other stoichiometries during the process leading to the
formation of the final pore structures in equilibrium.
Nevertheless, some questions remain unanswered or, at least,
poorly understood. For example, is the stoichiometry of the
pores of all actinoporins the same? Are multiple stoichiome-
tries possible under the same conditions? Could it be that
detergent treatments favor the formation of specific com-
plexes? Do the final pore structures constitute a thermody-
namically stable assembly? Do different toxin isoforms
produced by the same sea anemone species assemble into
the same structure and yield heteropores?
To answer these questions, we conceived a new approach,
taking advantage of the fact that the wild-type (WT) variants
of most actinoporins lack cysteine (Cys) residues in their
sequences. Building on the accumulated functional and
structural knowledge on actinoporins, and particularly
sticholysins, we created a single-cysteine mutant, StnI-T43C,
that enabled specific labeling with a high-quantum yield
fluorescent probe while keeping functional disturbance to a
minimum. Using this mutant, we have been able to study the
behavior of these proteins in solution and on membranes and,
using a FRET (Förster resonance energy transfer) approach, to
elucidate the stoichiometry of StnI and StnI−StnII pores.




(PSM), and egg sphingomyelin (eSM) were obtained from
Avanti Polar Lipids (Alabaster, AL). Maleimide-modified
ATTO-488 and ATTO-542 were obtained from Atto-Tec
GmbH (Siegen, Germany). All sticholysin variants were
produced in Escherichia coli, strain RB791, and purified to
homogeneity as described in refs 21 and 34. Briefly,
purification was performed using ion-exchange chromatog-
raphy (carboxymethyl-cellulose, CM-52) eluted using a linear
gradient of NaCl (0 to 0.3 M) followed by size-exclusion
chromatography (Biogel P2). Homogeneity of the preparation
was evaluated by means of sodium dodecyl sulfate−
polyacrylamide gel electrophoresis and amino acid analysis.
Methods. Protein Preparation. The mutant StnI-T43C
was produced using site-directed mutagenesis. Its design takes
advantage of the lack of Cys residues in sticholysins, enabling
them to be specifically labeled at a convenient position, safe
from the perspective of functionality, where the label is not
expected to interfere with either protein−protein interactions
or membrane recognition and binding (Figure 1).
The new mutant was characterized structurally and func-
tionally using circular dichroism, and hemolytic assays as
previously described.35 Its hemolytic activity was essentially the
same as that of the WT StnI variant, indicating that the
mutation did not affect any functionally important region of
the protein (Figure S1), as expected from the design (Figure 1
and Figure S2). For these assays, the mutant was previously
incubated with 0.5 mM TCEP to ensure that all potential
disulfide bonds were reduced.
StnI-T43C was specifically labeled at the introduced -SH
group using maleimide-modified ATTO probes (5−8-fold
molar excess) overnight after a previous 2 day incubation with
TCEP [tris(2-carboxyethyl)phosphine; 50:1 molar excess] in
phosphate buffer (140 mM NaCl and 10 mM phosphate) at
pH 7.4. The excess of free label was effectively removed using
Pierce Dye Removal Columns (Thermo Fisher Scientific)
following the manufacturer’s specifications. The yield of the
labeling procedures ranged between 17% and 25%, depending
on the batch. The efficiency of labeling was evaluated by means
of the absorption spectra of the sample, using the following
extinction coefficients: ε = 49450 M−1 cm−1 for StnI-T43C at
280 nm, ε = 9.0 × 104 M−1 cm−1 at 500 nm for ATTO-488,
and ε = 1.2 × 105 M−1 cm−1 at 542 nm for ATTO-542.
Corrections for label contributions at 280 nm were made using
the corresponding correction factors provided by the
manufacturer, which are 0.09 and 0.08 for ATTO-488 and
ATTO-542, respectively (see Figure S3 for the complete
absorption spectra). These correction factors represent the
absorbance of the label at 280 nm relative to their respective
maximum absorbances.
Vesicle Preparation. Lipid vesicles were prepared by mixing
selected methanol (hexane for Chol) solutions of lipids in the
desired lipid molar proportion. The organic solvent was
evaporated under a nitrogen flow at 40 °C. Dried lipid films
were then hydrated at 65 °C in a water bath for at least 30 min.
Suspended lipid vesicles were then extruded at hydration
temperature through 200 nm diameter polycarbonate filters.
Time-Resolved Fluorescence Anisotropy. Time-resolved
fluorescence measurements were performed using a Fluo-
Figure 1. (A) Position of the mutated residue, Thr43, in the structure
of StnI (Protein Data Bank entry 2KS4). Its replacement by a Cys
residue would not affect the membrane-binding region (α-helix
below) or the protein−protein interface (side of the protein in the
front). (B) Mutated residue in the context of an oligomer, showing
that it is unlikely to interfere with oligomerization (see Figure S2 for
further details). The figure was made by fitting the structure of StnI to
that of the octameric pore of FraC (Protein Data Bank entry 4TSY).
Made with UCSF Chimera.31
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Time100 spectrofluorimeter equipped with a PicoHarp300E
time-correlated single photon-counting module (PicoQuant
GmbH, Berlin, Germany) and polarizers. A 457 ± 15 nm
pulsed diode laser was used for excitation. Emission was
collected through a long-pass filter (>480 nm). When required,
neutral density filters were used to attenuate the excitation
intensity. The instrument response function (IRF) was
acquired using light scattered by buffer in the absence of
colored filters up to 10000 counts in the peak channel. Each
sample decay was recorded up to ∼20000 counts in the peak
channel. To avoid inner filter effects, the concentration of the
fluorophores was such that the optical density at the excitation
wavelength was ODl/2 < 0.05. Experiments were performed
under constant stirring. The temperature was controlled by a
Peltier element.
Anisotropy decays were analyzed using FluoFit Pro software
from PicoQuant. The G factor was recorded for each sample
and was always between 0.98 and 1.02. The fluorescence
anisotropy decay curves [r(t)] were fit using a model


















where αi and θi are the normalized amplitude and the
rotational correlation time of the ith component of the
anisotropy decay, respectively. The symbol r∞ is the limiting
anisotropy, which is related to the restrictions in the process of
depolarization. The number of exponential terms was always
the smallest required to obtain a satisfactory fit, as judged from
the value of the reduced χ2, the distribution of the residuals,
and the trace of the autocorrelation plot.












which is derived from the Perrin equation,36 modified to yield
the molecular diameter directly in angstroms, where θ is the
correlation time of the rotating unit in seconds, R is the ideal
gas constant (8.314 m3 Pa mol−1 K−1), T is the temperature in
kelvin, η is the viscosity of the solvent (0.94 × 10−3 Pa s), and
NA is Avogadro’s number. The numerical constants appearing
in the equation transform the radius into the diameter while
also transforming the output units. When using this equation,
an assumption is made that the overall shape of the rotating
unit is that of a sphere. This can be expected for molecules that
display a single correlation time.36
Calculation of the Förster Distance. The Förster distance
(R0) of the donor−acceptor pair used was calculated as





which yields R0 directly in angstroms. In the expression, κ
2 is
the orientation factor, set to 2/3, which represents the dynamic
isotropic limit (see Figure S4), n is the refractive index of the
medium, set to 1.33 (water), QD is the quantum yield of the
donor (0.8, according to the supplier), and J(λ) is the overlap
integral between the emission spectra of the donor and the
absorption spectra of the acceptor. The overlap integral is
calculated as
∫λ λ ε λ λ λ=
∞





where FD(λ) is the emission spectra of the donor with its area
normalized to 1 and εA(λ) is the acceptor spectra in M
−1 cm−1.
The calculated R0 for the ATTO-488/ATTO-542 FRET pair
was 63.8 Å. The R0 for the ATTO-488 self-transfer was 49.3 Å.
Steady-State Fluorescence Spectroscopy. Steady-state
fluorescence measurements were performed on a PTI Quanta-
Master spectrofluorimeter (Photon Technology International,
Lawrenceville, NJ). Sample excitation was set at 500 nm.
Emission was recorded between 507 and 675 nm to encompass
the spectra of both fluorophores. To avoid inner filter effects,
the concentration of the fluorophores was such that the optical
density at the excitation wavelength was ODl/2 < 0.05.
Experiments were performed under constant stirring. The
temperature was controlled by a Peltier element.
Stoichiometry of Oligomers from FRET. A model was
constructed to calculate the expected FRET efficiencies for
each possible stoichiometry in a way that was dependent on
the fraction of acceptor-labeled toxin in the sample, while the
fraction of donor was kept constant. Single-point mutants
allowed the assumption that the fluorophores were distributed
as the vertices of regular polygons (see Figure S5 for further
details about this and the method). The distance from the








where rc is the radius of the polygon, rmm is the distance
between fluorophores on adjacent subunits, and N is the
number of subunits per pore.
The value for rmm was 29.0 Å, as measured for a sticholysin
subunit (calculated from the correlation times). However, rc
cannot be used directly. Instead, the offset of the fluorophore
relative to the center of the protein has to be taken into
account. The distance to the center of the polygon to the
fluorophore is then





where rf is the distance from the mass center of the protein to
the labeled position as observed from above (distance on the z-
axis is not required) and ω is the angle between the line that
joins them and the prolongation of the line that unites the
center of the monomer and the center of the oligomer. The
values of rf and ω were measured as 10 Å and 66°, respectively,
based on the position of residue T43 on the three-dimensional
structure of StnI [Protein Data Bank (PDB) entry 2KS4].
Once rcf is known, the distance between any two subunits










where i and j are the indices of the subunits of interest. Usually,
assuming j = 1, as will be done from here onward (omitting
subscript j), eq 7 yields the distance between the selected
subunit (number 1) and the ith subunit. Distance values were
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where τD is the lifetime of the donor, which in our case is 4.1
ns.
To ensure the greatest precision, all possible arrangements
of all possible combinations of unlabeled and donor- and
acceptor-labeled subunits were calculated for each of the
stoichiometries considered, assuming that monomer associa-
tions were random and unbiased by the labeling. This was
achieved with a homemade Python program. The arrange-
ments of subunits were calculated taking into account possible
redundancies due to rotational symmetry. In all cases, it must
be maintained that ND + NA + NU = N [i.e., the sum of
unlabeled (NU), donor-labeled (ND), and acceptor-labeled
(NA) subunits must equal the total number of subunits].
For each of the possible arrangements, the expected FRET























where ENqν indicates that it is the FRET efficiency for a
stoichiometry of N subunits (for example, N = 8), a
combination q of unlabeled and donor- and acceptor-labeled
subunits (for example, ND = 1, NA = 3, and NU = 4), ordered in
a particular arrangement ν. For each arrangement, the
observed FRET efficiency will depend on how the subunits
are ordered within the oligomer. We assumed that monomer
associations were random and unaffected by the labeling;
hence, the observed FRET efficiency for each combination q
will be the average of the E values for all of the possible
arrangements, because we are assuming that all arrangements
are equally possible within each combination.
The observed FRET efficiency would then depend on the
fraction of donor- and acceptor-labeled toxins in the sample
( fA and f D, respectively). These fractions control which
combinations are more likely to occur. The respective fractions
of labeled and unlabeled subunits must equal one (i.e., fA + f D
+ f U = 1). The probability of each combination, including all of
its possible arrangements, is calculated as
= − !
− ! ! !
−P N N N f f f
N
N N N











which is a version of the trinomial distribution adapted to rule
out redundancies due to rotational symmetries. The sum of all
probabilities calculated in this manner must equal 1. This
probability is the weighting factor for the energy transfer
efficiencies of each combination. The final result yields the
expected FRET efficiency for a given stoichiometry and
fraction of labeling.
FRET efficiencies were measured in a large lipid:protein
(L:P) molar ratio to avoid energy transfer between different
pore complexes. The estimation of the right L:P ratio was
made as = σrav 2 , where rav is the average distance between
oligomers and σ is the surface density of the complexes.37
Thus, if the stoichiometry was 8, the average separation
between complexes would be ∼3R0. Under these conditions, if
the stoichiometry was equal to 4, the average separation would
still be ∼2R0, at which the energy transfer efficiency is <2%.
Larger L:P ratios could not be used due to experimental
limitations, namely, light scattering by large unilamellar vesicles
(LUVs), the availability of materials, and instrument
sensitivity. Comparison of the experimental data with the
model using root-mean-square deviations (RMSDs) allowed us
to estimate the stoichiometry of the pores of sticholysins. For
the calculation of the RMSDs, the error in each value was used
to calculate weighting factors, so that the most accurate values
contributed to the final RMSD.
Final protein mixtures were made by combination of
aliquots from WT (StnI and StnII, as indicated) and labeled
StnI (with donor or acceptor) stocks. The amounts of donor-
and acceptor-labeled mutants were calculated according to the
corresponding stock concentration and degree of labeling. The
same procedure was used when StnII was included. WT StnI
was added last, if needed, to adjust the final overall fraction of
labeling and total protein concentration to the desired values.
Throughout the study, StnI has been considered to be equal,
structurally and in terms of activity, to the unlabeled StnI-
T43C mutant, as evidenced by their practically indistinguish-
able CD spectra (both near and far UV) and hemolytic activity
(Figure S1).
All fluorescence experiments were performed in PBS (10
mM phosphate and 140 mM NaCl) at pH 7.4.
■ RESULTS
Motions of Sticholysins in Solution and on Mem-
branes. StnI-T43C was labeled with ATTO-488. The time-
resolved anisotropy decays of the toxin and the free label were
recorded for the following reasons: (1) as a way to further
ascertain that the labeling process had succeeded, (2) to
observe if the label was able to interact with the LUVs by itself,
and (3) with the intention of measuring the average
hydrodynamic size of the StnI monomers. For these measure-
ments, solutions in which only 2% of the total sticholysin was
labeled were used (i.e., WT StnI was added to the 17−25%
labeled mutant preparation to decrease the final overall degree
of labeling to 2%) (Figure 2). Under these conditions, only a
single, very short correlation time (0.2 ns) could be resolved
for the free label. StnI displayed two correlation times. The
faster one was ∼0.3 ns, very close to that of the free label,
accounting for segmental motions of the fluorophore. The
slower one was ∼2.95 ns and corresponded to the rotational
motions of the proteins within the solvent (Table 1). This last
correlation time could be used to estimate the molecular
diameters of the different sticholysin species presumably
present in the solution studied. The value obtained, 29.0 ±
1.3 Å, agrees with the molecular structures available, as
demonstrated when placing a sphere at the mass centers of
those structures. The time-dependent anisotropy did not decay
to zero, displaying a limiting anisotropy of ∼0.014.
These same anisotropy decays were then recorded in the
presence of DOPC/eSM/Chol LUVs (1:1:1 molar ratio) or
POPC/PSM LUVs (4:1 molar ratio). The anisotropy decay of
the free label in the presence of lipids was essentially identical
(Table 1) to that observed in their absence, indicating that no
direct interaction was established between the fluorophore and
the vesicles. Energy transfer is a phenomenon that is known to
reduce anisotropy.36−38 Hence, the fractional labeling of
sticholysins was kept low, at 2%, to minimize potential energy
transfer between neighboring subunits in the pores. The L:P
molar ratio was also high, beyond saturation, so that energy
transfer between subunits of different pores was unlikely. At
the same time, maximum possible binding of the available
toxin was achieved. The observed rapid correlation time did
not substantially vary from the previously measured time in
Biochemistry pubs.acs.org/biochemistry Article
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any of the subsequent measurements. The slow correlation
time was slightly increased when Chol-containing LUVs were
used but decreased when LUVs lacking Chol were employed.
The limiting anisotropy was larger in both cases, in the range
of 0.03−0.04, indicating the restricted mobility of the
membrane-bound proteins (Table 1). Correlation times
could not be used to calculate molecular sizes this time due
to the restrictions imposed by the membrane on the mobility
of the proteins.
Oligomerization in Solution. Previous reports have
shown that StnII can oligomerize in solution.39 Hence, energy
transfer in solution, prior to pore formation on membranes,
could be expected to occur, at least to some extent. With this
background, and as a first approach, steady-state anisotropy of
StnI-ATTO-488 was also measured. Anisotropy is expected to
decrease as a consequence of energy transfer.36−38 This is
consequence of an effective larger displacement of the emission
dipole (that of the acceptor molecule) relative to the original
absorption dipole (of the molecule acting as a donor), larger
than what could be achieved solely by molecular motions.
Hence, the steady-state anisotropy of ATTO-488-labeled StnI
in solution was measured at increasing degrees of labeling
(DoL) (Figure S6). Only at high DoL values did the
anisotropy appear to decrease slightly, though not significantly.
This effect was more noticeable for membrane-bound toxins
(Figure S6).
Therefore, to improve the resolution of the experiment, a
sample of ATTO-488-labeled StnI-T43C (hereafter StnI-488
or donor) was titrated with ATTO-542-labeled StnI-T43C
(hereafter StnI-542 or acceptor). The R0 of this FRET pair was
significantly larger than the distance over which the previous
approach was effective (only at r < 0.8R0
38). WT StnI was
included to control the exact fractions of donor- and acceptor-
labeled populations. The relative fractions of both the donor
and the acceptor in the sample varied as a consequence of the
titration process, while the total amount of donor (which is
responsible for the measured signal) was constant. The
measured FRET efficiencies were plotted as a function of the
fraction of the acceptor, which was deemed more representa-
tive than the fraction of the donor or unlabeled toxin (Figure
3). A small increase in the level of energy transfer was observed
as a function of the level of the acceptor in the sample,
indicative of the presence of oligomers.Figure 2. Time-dependent anisotropy decays of StnI labeled with
ATTO-488 free in solution (degree of labeling of 2%, red) or in the
presence of DOPC/eSM/Chol (1:1:1) membranes (L:P molar ratio
of 160, blue). The decay of the free ATTO-488 label was also
recorded (black). Traces of residuals for each of the fits are shown
below. The order of the graphs is the same as that of the legend. The
decay recorded using a 4:1 POPC:PSM ratio has been omitted for the
sake of clarity.
Table 1. Parameters of the Anisotropy Decays of ATTO-488, StnI (degree of labeling of 2%), in the Absence and Presence of
Lipids (1:1:1 DOPC:eSM:Chol with an L:P molar ratio of 160; 4:1 POPC:PSM with an L:P molar ratio of 160)a
r1 θ1 (ns) r2 θ2 (ns) r∞
ATTO-488 0.125 ± 0.005 0.228 ± 0.012 − − 0.000 ± 0.0004
ATTO-488 with DOPC/eSM/Chol 0.135 ± 0.006 0.232 ± 0.012 − − 0.001 ± 0.0004
StnI 0.200 ± 0.008 0.299 ± 0.030 0.089 ± 0.006 2.851 ± 0.530 0.014 ± 0.002
StnI with DOPC/eSM/Chol 0.195 ± 0.009 0.267 ± 0.034 0.088 ± 0.004 2.979 ± 0.587 0.040 ± 0.003
StnI with POPC/PSM 0.157 ± 0.007 0.224 ± 0.020 0.103 ± 0.005 2.273 ± 0.170 0.031 ± 0.002
aThe initial anisotropies (ri) and correlation times (θi) of each component together with the limiting anisotropy (r∞) are indicated. Values were
obtained from fitting, and errors from bootstrap analysis.
Figure 3. FRET efficiency observed for donor-labeled StnI with WT
StnI (solid black trace) or WT StnII (dashed red trace). Initially, both
samples contained 11.9% of donor-labeled StnI and 29.1% of the
indicated WT variant, with the remainder being unlabeled StnI-T43C.
The samples were then titrated with acceptor-labeled StnI (labeled
25.9%) to a final composition of 5% donor, 15% acceptor, and 12.3%
WT variant, the remainder being unlabeled StnI-T43C. Values are
averages of three replicates ± the standard error of the mean. A
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Incidentally, it has been shown that a minimal amount of
StnII, just 1%, is capable of greatly enhancing the hemolytic
activity of StnI, presumably by facilitating the binding step of
the pore formation process.40 If that is so, then StnII could also
be expected to oligomerize with StnI while in solution. The
results of titrating StnI-488 with StnI-542, albeit replacing WT
StnI with StnII, showed that the efficiency of energy transfer
was more pronouncedly increased than that observed using
WT StnI (Figure 3).
Stoichiometry of StnI Pores from FRET in 1:1:1 DOPC/
eSM/Chol LUVs. Energy transfer was also measured directly
in sticholysin oligomers assembled on membranes. For that
reason, lipid vesicles were added to a 100 nM mixture of StnI
to achieve a final L:P molar ratio of 160. The fraction of donor-
labeled proteins in the sample was kept constant at 0.05,
whereas the fraction of acceptor-labeled monomers was varied
between experiments and increased to ≤0.15. FRET efficiency
values were obtained from steady-state data using quenched
donor emission as measured from the deconvoluted total
sample emission (Figure S8). These values were plotted as a
function of the acceptor content in the sample and compared
with the theoretical predictions (Figure 4a). To properly
evaluate which of the theoretical traces better described the
experimental data, the RMSD was calculated for the
experimental values relative to each of the theoretical traces,
using the error of each experimental value for weighting the
calculation (Figure 4b). The signal of StnI pores on 1:1:1
DOPC/eSM/Chol membranes best agreed with that of
octameric ensembles. However, experimental resolution and
model limitations did not permit us to rule out the formation
of oligomers equal to or larger than heptamers, based solely on
this result.
Is the Stoichiometry of StnI Pores from FRET in 4:1
POPC/PSM Membranes Different? The experiment and
subsequent analysis were repeated with vesicles without Chol,
to determine if the presence of Chol had a substantial effect on
oligomerization. This time, the L:P molar ratio was increased
to 320, in spite of increased lipid-induced light scattering, to
ensure complete binding due to the comparatively lower
affinity of StnI for membranes lacking Chol.41 Surprisingly, the
results showed that the signal from StnI did not follow the
trend expected from any of the theoretical predictions (Figure
4c), indicating that the assumptions of the model are not valid
for this situation.
A 12% StnII in the StnI Sample Does Not Affect the
Stoichiometry. The experiment was performed again for each
lipid composition. This time, however, the sample included
12.3% StnII, to ascertain the stoichiometry of the pores formed
when using a mixture of both proteins. The results showed that
the presence of StnII did not change the trends observed in its
absence (Figure 5a,c). The distribution of RMSD values of the
experiment performed in the presence of Chol (Figure 5b)
closely resembled that observed in the absence of StnII,
indicating that the stoichiometry is conserved in Chol-
containing membranes. The unexpected experimental trend
that we had observed for membranes without Chol was also
maintained, again showing that the theoretical assumptions
regarding the process of pore formation do not adequately
describe the process that takes place in the absence of Chol
(Figure 5c).
Figure 4. (A) Experimental energy transfer efficiency values (●) obtained using labeled StnI in a combination of 1:1:1 DOPC/eSM/Chol
membranes plotted with the theoretical predictions made for stoichiometries from 2 to 10 (11 to 14 removed for the sake of clarity). From bottom
to top, predictions for 2, 3, 4, 5, etc., respectively (as indicated in the figure). Predictions from 6 on can barely be distinguished at this scale. With
the conditions considered, the maximum FRET efficiency is reached for heptamers, being slowly reduced for higher values (see Figure S9). (B)
Root-mean-square deviations (RMSDs) obtained for the experimental values on the left compared to each of the predictions. (C) FRET efficiency
values observed for labeled StnI in combination with 4:1 POPC:PSM LUVs. Experimental values do not follow the expected trends.
Figure 5. (A) Experimental energy transfer efficiency values (●) obtained using labeled StnI with 12.3% StnII in a combination of 1:1:1 DOPC/
eSM/Chol membranes plotted with the theoretical predictions as in Figure 4. (B) RMSDs for each of the predictions. In this case, the difference
observed between the stoichiometries is reduced compared with the previous result in the absence of StnII. (C) FRET efficiency values observed
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Sticholysin Pores Are Not Remodeled Once Formed.
The results from studies using electrophysiological measure-
ments suggested that sticholysin pores might be unstable,
based on the noise level of the conductance measured
compared with those observed for β-pore-forming toxins.42
One possibility is that this noisiness was simply caused by
thermal oscillations of the system, because the lumen of the
pore would be lined by the N-terminal α-helices of sticholysins
and lipids, with few direct interactions between the
components other than van der Waals forces. However, the
possibility that, once formed, pores would be under continuous
remodeling, with monomers moving from one complex to
another, has also been proposed.
To test this idea, StnI or StnII, to a final increment of 57
nM, was added to 100 nM StnI preincubated with lipids,
already including 5% donor and 15% acceptor proteins. The
L:P molar ratio was initially set to 240. That way, the final L:P
molar ratio after the addition of the extra protein was 160,
comparable to the results of the assays described above. In
neither case did the observed FRET efficiency vary after the
addition of extra unlabeled protein, regardless of whether it
was StnI or StnII (Figure 6 and 7, respectively). This suggested
that once equilibrium was reached, previously formed pores
were not disturbed by newly added toxin molecules and
maintained the same monomers that oligomerized in the first
place, resulting in a constant FRET signal.
■ DISCUSSION
In this study, several aspects of the process of pore formation
by sticholysins were investigated using the single-cysteine StnI
mutant T43C, labeled with ATTO-488 and ATTO-542. Using
time-resolved measurements, the hydrodynamic size of StnI
was measured as 29.0 ± 1.3 Å, which is in good agreement
with the dimensions of a sticholysin monomer according to
structural determination techniques.27,28 The anisotropy decay
of the soluble protein reveals a correlation time that agrees
with the molecular size of the protein but also shows that some
oligomers are present, as indicated by the fact that the limiting
anisotropy was slightly larger than 0 (Figure 2 and Table 1).
These results agree with the previous observations on StnII,
showing that it can oligomerize up to tetrameric ensembles in
solution while mainly maintaining a monomeric nature.39
Delving further into that line of research, titration experi-
ments were used to corroborate the presence of oligomers in
solution. Using solely StnI, the presence of oligomers was
detected as a slight increase in FRET efficiency. When StnII
was included, a further increase in the efficiency of energy
transfer was observed (Figure 3). This result supports the
previously observed behavior indicating that StnII promotes
the binding of StnI to the membrane, presumably by binding
to it while still in solution.40 This result suggests not only that
the number of oligomers in solution is larger but also that there
are higher-order oligomers, such as trimers and tetramers
(given that StnII was not labeled, it could increase FRET
efficiency only if trimers and/or tetramers occur).
The FRET approach was then taken one step further to
calculate the stoichiometry of sticholysin pores in lipid model
vesicles. The signal from labeled-StnI in 1:1:1 DOPC/eSM/
Chol membranes was best described by the theoretical
prediction that assumed an octameric complex. However,
due to physical constraints, namely, the R0 of the FRET pair
and the distance between labels on neighboring subunits, the
prediction of the model became increasingly similar as the
oligomerization number was increased (Figure S9). These
experimental results rule out the existence of a detectable
number of oligomers of five or fewer subunits, but
simultaneously, any larger stoichiometry should not be entirely
discarded, even if the prediction obtained under the
assumptions of octamers is the one that best agrees with the
experiment (Figure 4a). Using a strategy similar to ours but
based on spin labeling and electron paramagnetic resonance
spectroscopy, it has been recently concluded that StnI in a
membrane would exhibit an oligomeric architecture with
heterogeneous stoichiometry of predominantly eight or nine
protomers, which agrees with the available structural
models.33,43 In fact, the results presented here are compatible
with the possibility that several other stoichiometries occurred
at once, yielding the same signal as if all were octamers. It is
also important to remark that our approach observes
oligomeric structures in equilibrium, without contemplating
the trajectory on the membrane followed by the different
Figure 6. Emission spectra of StnI with 5% donor labeling and 15%
acceptor labeling in solution (solid black line), with 1:1:1 DOPC/
eSM/Chol membranes (solid red line), and after addition of extra 57
nM unlabeled StnI (solid purple line). Deconvoluted donor emission
is also shown as the corresponding dashed line. The later addition of
StnI did not affect the FRET efficiency, indicating that pores are not
remodeled.
Figure 7. Emission spectra of StnI with 5% donor labeling and 15%
acceptor labeling in solution (solid black line), with 1:1:1 DOPC/
eSM/Chol membranes (solid red line), and after addition of extra 57
nM unlabeled StnII (solid purple line). Deconvoluted donor emission
is shown as the corresponding dashed line. As for StnI, the addition of
StnII did not affect FRET efficiency, indicating stable pores.
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oligomeric structures during pore formation and/or remodel-
ing before reaching their stable final assembly.
Interestingly, the inclusion of 12.3% StnII did not affect the
distribution of the RMSD values observed for StnI alone,
indicating that StnII did not affect the overall stoichiometry of
the pores at equilibrium. It could be argued that StnII did not
oligomerize with StnI. However, this would contradict the
observed ability of StnII to enhance StnI binding40 and imply
that the observed signal should shift upward because the partial
fraction of labeling would be larger in the StnI-only complexes
than accounted for in the calculations, which assume that StnII
is part of the total toxin population. This effect was not
observed. In fact, the presence of oligomeric structures
containing both StnI and StnII has been detected before, in
the presence of vesicles with a composition identical to the
ones used now, employing cross-linking experiments.40 This is
the first time, however, that it has been shown that the
stoichiometry is conserved when both proteins are mixed. This
fact also suggests that the essential residues responsible for
protein−protein interactions should be conserved between
both sticholysin isoforms. At this point, it is interesting to
remember that oligomerization is promoted by the presence of
StnII and that two of the only 12 residues that differ between
StnI and StnII are located very close to or at the protein−
protein interfaces. These two residues are Tyr148 and Gln149
in StnI and His147 and Glu148 in StnII. Overall, the properties
of these amino acids are conserved in both residue pairs. On
this basis, we can predict the nature of the complementary
residues located on the other side of the protein. Those should
be capable of both hydrogen bonding and perhaps also
establishing salt bridges, and one of them would have to be
cationic so that it could establish a cation−π interaction with
the aromatic rings observed. Inspection of the three-dimen-
sional structures reveals that there is, in fact, such a pair of
residues, appropriately standing out from the protein. These
are Arg126 and Lys124 in StnI and Arg125 and Lys123 in
StnII. So far, the difference in activity between StnI and StnII
has been attributed, to a very large degree, to the different
strength of attachment of the N-terminal α-helix to the β-
sandwich, as well as to its different hydropathy profile.35
However, it is also possible that a stronger monomer−
monomer interaction, which is feasible only with the residues
of StnII (a possible salt bridge between Glu148 and Lys123/
Lys124), could intervene, shifting the equilibrium in solution
to the multimeric forms, which could in turn favor membrane
binding and, certainly, oligomerization (Figure 8).
The results obtained when using membranes that lack Chol
are, at first glance, surprising. In all cases, the experimental
values do not follow the predictions. In addition, their trend
does not agree with what would be expected if the pores
clustered, which would be higher than expected E values,
which would be the consequence of an increased probability of
energy transfer between different oligomers due to their
higher-than-expected proximity. The fact that the first points,
corresponding to the lower acceptor fractions, are closer to the
estimations and then cease to rise accordingly, at larger fraction
values, could indicate that the binding unit for membranes
without Chol would be sticholysin dimers/oligomers. At low
acceptor levels in the sample, the expected E is less dependent
on the presence of acceptors at subunit i + 1 (from a donor
placed at i). However, the more the acceptor fraction increases,
the greater the relevance is of the probability of finding
acceptors, simultaneously, at positions i + 1 and i − 1. Because
donor- and acceptor-labeled proteins are mixed right before
the measurements are performed, and in the total final volume,
complete shuffling of the variants in the oligomers might not
occur quickly enough. Consequently, oligomers in the sample
would rarely have donor−acceptor pairs, yielding the observed
effect. This is compatible with previous results indicating that,
in fact, dimers are required for membrane binding in the
absence of Chol.33,44 It is, therefore, possible that Chol’s effect
on SM’s headgroup orientation45 aids in SM recognition,
permitting the dominant form in solution, monomers, to
directly bind those membranes. We confirmed that, in all cases,
FRET was a consequence of specific membrane binding and
SM recognition by incubation of a labeled sample with POPC
vesicles, which did not affect the emission of the sample
(Figure S10).
Finally, we have shown that sticholysin pores are stable once
in equilibrium and do not undergo any kind of subunit
exchange when new monomers are added to the sample. This
certainly does not happen on the time scale used (2−5 min),
which is much greater (seconds) than that used in the
electrophysiology experiments that prompted the question.
Figure 8. Model homodimers of (A) StnI and (B) StnII. The residues shown are the same in both cases for the monomer on the left, Lys124 and
Arg126 of StnI (Lys123 and Arg125 of StnII). For the monomer on the right, the amino acids differ. For StnI, they are Tyr148 and Gln149,
whereas for StnII, they are His147 and Glu148. The orientation of the residues is not necessarily that found upon oligomerization, because the
structures were obtained in solution (A) and by crystallization (B). The Arg residue could interact with either of the aromatic residues, by hydrogen
bonding or by a cation−π interaction. The latter can, in fact, be observed in the dimer structure published for FraC (PDB entry 4TSL32) between
its equivalent amino acids. The Lys residue probably forms a hydrogen bond with Gln149 and a salt bridge with Glu148. This figure was made
using the three-dimensional structures of StnI (PDB entry 2KS4) and StnII (PDB entry 1GWY), superimposing them with the octameric pore of
FraC (PDB entry 4TSY), which has been shown to be compatible with the stoichiometry of sticholysins.
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■ CONCLUSIONS
In this work, we have presented evidence disproving that
tetramers are the oligomerization assembly of StnI at
equilibrium. The inclusion of 12.3% StnII showed no
significant effect on the stoichiometry-dependent energy
transfer efficiency, indicating that the stoichiometry is
conserved regardless of the composition of the pores. Both
of these results would support the X-ray structure obtained for
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